Persistent twenty-four hour changes in liver and bone marrow despite suprachiasmatic nuclei ablation in mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 287, Issue 4 56-4, 2004, Pages

  Filipski, Elisabeth ^a   King, Verdun M ^d   Etienne, Marie Christine ^b   Li, XiaoMei ^a   Claustrat, Bruno ^c   Granda, Teresa G ^a   Milano, Gérard ^b   Hastings, Michael H ^e   Lévi, Francis ^a,f  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^f INSERM   (France)

Author keywords

Cancer chronotherapeutics; Cell cycle; Circadian coordination; Cortisol; Dihydropyrimidine dehydrogenase

Indexed keywords

CORTICOSTERONE; DIHYDROPYRIMIDINE DEHYDROGENASE; GLUTATHIONE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BONE MARROW CELL; BRAIN FUNCTION; CELL CYCLE; CELL FUNCTION; CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DARKNESS; ELECTROCOAGULATION; LEUKOCYTE COUNT; LIGHT; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPRACHIASMATIC NUCLEUS; TELEMETRY;

ANESTHESIA; ANIMALS; ANTIMETABOLITES; BLOOD CELL COUNT; BODY TEMPERATURE; BONE MARROW; BONE MARROW CELLS; CELL CYCLE; CIRCADIAN RHYTHM; CORTICOSTERONE; DIHYDROURACIL DEHYDROGENASE (NADP); FLUOROURACIL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; LIVER; MALE; MICE; MICE, INBRED STRAINS; ORGANOPLATINUM COMPOUNDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPRACHIASMATIC NUCLEUS;

EID: 4644256849     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00085.2004     Document Type: Article

References (51)

1. Akhtar RA, Reddy AB, Maywood ES, Clayton JD, King VM, Smith AG, Gant TW, Hastings MH, and Kyriacou CP. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol 12: 540-50, 2002.
2. Balsalobre A. Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblasts. Curr Biol 10: 1291-1294, 2000.
3. Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, Schutz G, and Schibier U. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289: 2344-2347, 2000.
4. Belanger PM, Desgagne M, and Bruguerolle B. Circadian periodicity in the glutathione concentration of rat liver. Ann Rev Chronopharmacol 5: 215-218, 1988.
5. Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky WJ, and Ben-David Y. Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol 58: 1793-1801, 2001.
6. Boughattas N, Lévi F, Fournier C, Lemaigre G, Roulon A, Hecquet B, Mathé G, and Reinberg A. Circadian rhythm in toxicities and tissue uptake of 1,2-diaminocyclohexane oxalatoplatinum in mice. Cancer Res 49: 3362-3368, 1989.
7. Boughattas NA, Levi F, Fournier C, Hecquet B, Lemaigre G, Roulon A, Mathe G, and Reinberg A. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice. J Pharmacol Exp Ther 255: 672-679, 1990.
8. Bourin P, Ledain AF, Beau J, Mille D, and Levi F. In-vitro circadian rhythm of murine bone marrow progenitor production. Chronobiol Int 19: 57-67, 2002.
9. Brown SA, Zumbrunn G, Fleury-Olela F, Preitner N, and Schibler U. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr Biol 12: 1574-1583, 2002.
10. Buijs RM, la Fleur SE, Wortel J, Van Heyningen C, Zuiddam L, Mettenleiter TC, Kalsbeek A, Nagai K, and Niijima A. The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons. J Comp Neurol 464: 36-48, 2003.
11. Castillo L, Milano G, Santini J, Demard F, and Pierrefite V. Analysis of retinoic acid receptor β expression in normal and malignant laryngeal mucosa by a sensitive and routine applicable reverse transcription-polymerase chain reaction-linked immunosorbent assay method. Clin Cancer Res 3: 2137-2142, 1997.
12. Cure H, Chevalier V, Adenis A, Tubiana-Mathieu N, Niezgodzki G, Kwiatkowski F, Pezet D, Perpoint B, Coudert B, Focan C, Levi F, Chipponi J, and Chollet P. Phase II trial of chronomodulated infusion of high-dose fluorouracil and L-folinic acid in previously untreated patients with metastatic colorectal cancer. J Clin Oncol 20: 1175-1181, 2002.
13. De Prins J and Hequet B. Data processing in chronobiological studies. In: Biologic Rhythms in Clinical and Laboratory Medicine, edited by Touitou Y and Haus E. Berlin: Springer, 1992.
14. Delaunay F and Laudet V. Circadian clock and microarrays: mammalian genome gets rhythm. Trends Genet 18: 595-597, 2002.
15. Deprés-Brummer P, Bourin P, Pages N, Metzger G, and Lévi F. Persistent T lymphocyte rhythms despite suppressed circadian clock outputs in rats. Am J Physiol Regul Integr Comp Physiol 273: R1891-R1899, 1997.
16. Filipski E, King VM, Li XM, Granda TG, Mormont MC, Liu XH, Claustrat B, Hastings MH, and Lévi F. Host circadian clock as a control point in tumor progression. J. Natl Cancer Inst 94: 690-697, 2002.
17. Grundschober C, Delaunay F, Puhlhofer A, Triqueneaux G, Laudet V, Bartfai T, and Nef P. Circadian regulation of diverse gene products revealed by mRNA expression profiling of synchronized fibroblasts. J Biol Chem 276: 46751-46758, 2001.
18. Hara R, Wan K, Wakamatsu H, Aida R, Moriya T, Akiyama M, and Shibata S. Restricted feeding entrains liver clock without participation of the suprachiasmatic nucleus. Genes Cells 6: 269-278, 2001.
19. Harris BE, Song R, Soong SJ, and Diasio RB. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluororuracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res 50: 197-201, 1990.
20. Hastings MH, Best JD, Ebling FJP, Maywood ES, McNulty S, Schurov I, Selvage D, Sloper P, and Smith KL. Entraiment of the circadian clock. Brain research. III. Hypothalamic integration of circadian rhythms. In: Progress in Brain Research, edited by Buijs RM, Kalsbeek A, Romijn HJ, Pennartz CMA, and Mirmiran M. Amsterdam: Elsevier Science, 1996, vol. 111, p. 147-154.
21. Hastings M, Reddy AB, and Maywood ES. A clockwork web: circadian timing in brain and periphery in health and disease. Nat Rev Neuroscience 4: 649-664, 2003.
22. Honma S, Honma K, Shirakawa T, and Hiroshige T. Rhythms in behaviors, body temperature and plasma corticosterone in SCN lesioned rats given methamphetamine. Physiol Behav 44: 247-55, 1988.
23. Hrushesky WJM. Circadian timing of cancer chemotherapy. Science 228: 73-75, 1985.
24. Klein DC, Moore RY, and Reppert S. Suprachiasmatic Nucleus. The Mind's Clock. Oxford, UK: Oxford Univ. Press, 1991.
25. Kriegsfeld LJ, LeSauter J, and Silver R. Targeted microlesions reveal novel organization of the hamster suprachiasmatic nucleus. J Neurosci 24: 2449-2457, 2004.
26. Lévi F. Circadian chronotherapy for human cancers. Lancet Oncology 2: 307-315, 2001.
27. Lévi F, Zidani R, and Misset JL for the International Organization for Cancer Chronotherapy. Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 350: 681-686, 1997.
28. Li XM, Metzger G, Filipski E, Boughattas N, Lemaigre G, Hecquet B, Filipski J, and Lévi F. Pharmacologic modulation of reduced glutathione (GSH) circadian rhythms by buthionine sulfoximine (BSO): relationship with cisplatin (CDDP) toxicity in mice. Toxicol Appl Pharmacol 43: 281-290, 1997.
29. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
30. Masubuchi S, Honma S, Abe H, Nakamura W, and Honma K. Circadian activity rhythm in methamphetamine-treated Clock mutant mice. Eur J Neurosci 14: 1177-1180, 2001.
31. Moore RY and Eichler VB. Loss of circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 42: 201-206, 1972.
32. Mormont MC, Bogdan A, Cormont S, Touitou Y, and Lévi F. Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: relevance for clinical outcome. Anticancer Res 22: 1243-1250, 2002.
33. Mormont MC, Langouet AM, Claustrat B, Bogdan A, Marion S, Waterhouse J, Touitou Y, and Levi F. Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status. Chronobiol Int 19: 141-155, 2002.
34. Mormont MC and Lévi F. Circadian system alterations during cancer processes: a review. Int J Cancer 70: 241-247, 1997.
35. Mormont MC and Lévi F. Cancer chronotherapy: principles, applications and perspectives. Cancer 97: 155-169, 2003.
36. Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, Lellouch J, Misset JL, Touitou Y, and Levi F. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6: 3038-3045, 2000.
37. Mrosovsky N. Masking: history, definitions, and measurement. Chronobiol Int 16: 415-429, 1999.
38. Nagai K, Nishio T, Nakagawa H, Nakamura S, and Fukuda Y. Effect of bilateral lesions of the suprachiasmatic nuclei on the circadian rhythm of food-intake. Brain Res 142: 384-389, 1978.
39. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, and Hogenesch JB. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109: 307-20, 2002.
40. Porsin B, Formento JL, Filipski E, Etienne MC, Francoual M, Renée N, Magné N, Lévi F, and Milano G. Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver comparison between enzyme activity and gene expression. Eur J Cancer 39: 822-828, 2003.
41. Reppert SM and Weaver DR. Coordination of circadian timing in mammals. Nature 418: 935-941, 2002.
42. Schibler U and Sassone-Corsi P. A web of circadian pacemakers. Cell 111: 919-922, 2002.
43. Sephton SE, Sapolsky RM, Kraemer HC, and Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92: 994-1000, 2000.
44. Servière J, Liu XH, Filipski E, Li XM, Bertel O, Caillol M, Chambille I, Lavialle M, and Lévi F. Rôle des noyaux suprachiasmatiques dans la chronopharmacologie: effets de leur destruction sur les variations circadiennes du cycle cellulaire et du glutathion chez le Rat (étude préliminaire). Proc 30th Congr Ann Soc Francophone Chronobiol Groupe d'Etudes des Rythmes Biol Lyon, 25-27 Mai 1998.
45. Svardal AM, Mansoor MA, and Ueland PM. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem 184: 338-346, 1990.
46. Tampellini M, Filipski E, Liu XH, Lemaigre G, Li XM, Vrignaud P, François E, Bissery MC, and Lévi F. Docetaxel chronopharmacology in mice. Cancer Res 58: 3896-904, 1998.
47. Terazono H, Mutoh T, Yamaguchi S, Kobayashi M, Akiyama M, Udo R, Ohdo S, Okamura H, and Shibata S. Adrenergic regulation of clock gene expression in mouse liver. Proc Natl Acad Sci USA 100: 6795-6800, 2003.
48. Yagita K and Okamura H. Forskolin induces circadian gene expression of rPer1, rPer2 and dbp in mammalian rat-1 fibroblasts. FEBS Lett 465: 79-82, 2000.
49. Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M, Block GD, Sakaki Y, Menaker M, Tei H, and Yamazaki S. Resetting central and peripheral circadian oscillators in transgenic rats. Science 288: 682-685, 2000.
50. Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH, Buhr ED, Siepka SM, Hong HK, Oh WJ, Yoo OJ, Menaker M, and Takahashi JS. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci USA 101: 5339-5346, 2004.
51. Zhang R, Lu Z, Liu T, Soong SJ, and Diasio RB. Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy. Cancer Res 53: 2816-2822, 1993.